BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bertolini A, Fiorotto R, Strazzabosco M. Bile acids and their receptors: modulators and therapeutic targets in liver inflammation. Semin Immunopathol 2022;44:547-64. [PMID: 35415765 DOI: 10.1007/s00281-022-00935-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Takimoto Y, Chu PS, Nakamoto N, Hagihara Y, Mikami Y, Miyamoto K, Morikawa R, Teratani T, Taniki N, Fujimori S, Suzuki T, Koda Y, Ishihara R, Ichikawa M, Honda A, Kanai T. Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis. iScience 2023;26:106220. [PMID: 36876136 DOI: 10.1016/j.isci.2023.106220] [Reference Citation Analysis]
2 Ricciuto A, Kamath BM, Hirschfield GM, Trivedi PJ. Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: a coming of age or an age-ist problem? J Hepatol 2023:S0168-8278(23)00162-9. [PMID: 36870613 DOI: 10.1016/j.jhep.2023.02.030] [Reference Citation Analysis]
3 Wang J, Zhu N, Su X, Gao Y, Yang R. Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis. Cells 2023;12. [PMID: 36899929 DOI: 10.3390/cells12050793] [Reference Citation Analysis]
4 Kasztelan-Szczerbinska B, Rycyk-Bojarzynska A, Szczerbinska A, Cichoz-Lach H. Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies-A Critical Overview. Nutrients 2023;15. [PMID: 36771465 DOI: 10.3390/nu15030760] [Reference Citation Analysis]
5 Merlen G, Bidault-jourdainne V, Doignon I, Garcin I, Tordjmann T. The bile acid receptor TGR5 and cholestasis. Explor Dig Dis 2022. [DOI: 10.37349/edd.2022.00011] [Reference Citation Analysis]
6 Bacalia KMA, Tveter KM, Palmer H, Douyere J, Martinez S, Sui K, Roopchand DE. Cannabidiol Decreases Intestinal Inflammation in the Ovariectomized Murine Model of Postmenopause. Biomedicines 2022;11. [PMID: 36672582 DOI: 10.3390/biomedicines11010074] [Reference Citation Analysis]
7 Fiaschini N, Mancuso M, Tanori M, Colantoni E, Vitali R, Diretto G, Lorenzo Rebenaque L, Stronati L, Negroni A. Liver Steatosis and Steatohepatitis Alter Bile Acid Receptors in Brain and Induce Neuroinflammation: A Contribution of Circulating Bile Acids and Blood-Brain Barrier. Int J Mol Sci 2022;23. [PMID: 36430732 DOI: 10.3390/ijms232214254] [Reference Citation Analysis]
8 Abenavoli L, Maurizi V, Rinninella E, Tack J, Di Berardino A, Santori P, Rasetti C, Procopio AC, Boccuto L, Scarpellini E. Fecal Microbiota Transplantation in NAFLD Treatment. Medicina 2022;58:1559. [DOI: 10.3390/medicina58111559] [Reference Citation Analysis]
9 Lu L, Xiong Y, Lin Z, Chu X, Panayi AC, Hu Y, Zhou J, Mi B, Liu G. Advances in the therapeutic application and pharmacological properties of kinsenoside against inflammation and oxidative stress-induced disorders. Front Pharmacol 2022;13:1009550. [DOI: 10.3389/fphar.2022.1009550] [Reference Citation Analysis]
10 Humphry N. Recent Findings in the Gut-Liver Axis and Associated Disease Therapy. EMJ Hepatol 2022. [DOI: 10.33590/emjhepatol/10154221] [Reference Citation Analysis]
11 Floreani A, Gabbia D, De Martin S. Update on the Pharmacological Treatment of Primary Biliary Cholangitis. Biomedicines 2022;10:2033. [DOI: 10.3390/biomedicines10082033] [Reference Citation Analysis]
12 Zhou S, You H, Qiu S, Yu D, Bai Y, He J, Cao H, Che Q, Guo J, Su Z. A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARα) and farnesoid X receptor (FXR). Biomed Pharmacother 2022;154:113577. [PMID: 35988420 DOI: 10.1016/j.biopha.2022.113577] [Reference Citation Analysis]
13 Lei Z, Rong H, Yang Y, Yu S, Zhang T, Chen L, Nie Y, Song Q, Hu Q, Guo J. Loperamide Induces Excessive Accumulation of Bile Acids in the Liver of Mice with Different Diets. Toxicology 2022. [DOI: 10.1016/j.tox.2022.153278] [Reference Citation Analysis]
14 Mori H, Svegliati Baroni G, Marzioni M, Di Nicola F, Santori P, Maroni L, Abenavoli L, Scarpellini E. Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota. Metabolites 2022;12:647. [DOI: 10.3390/metabo12070647] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Lai Q, Ma Y, Bai J, Zhuang M, Pei S, He N, Yin J, Fan B, Bian Z, Zeng G, Lin C. Mechanisms for Bile Acids CDCA- and DCA-Stimulated Hepatic Spexin Expression. Cells 2022;11:2159. [PMID: 35883602 DOI: 10.3390/cells11142159] [Reference Citation Analysis]
16 Schramm C, Oo YH, Lohse AW. Tolerance and autoimmunity in the liver. Semin Immunopathol 2022;44:393-5. [PMID: 35788895 DOI: 10.1007/s00281-022-00952-6] [Reference Citation Analysis]